Glyburide
Product Images NDC 66336-712

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Glyburide (NDC 66336-712). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Dispensing Solutions, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ndc 66336-0712-xx (Ndc 66336 0712 Xx Teva)

Label for Glyburide 6 mg micronized tablets, product NDC 66336-0712 from Dispensing Solutions, Inc. The label includes instructions for oral use with the first meal of the day and warnings about alcohol and photosensitivity. It shows lot and expiration information marked as sample, storage temperature, and barcodes.*

FDA Label Image

Glyburide Structural Formula (E7421730 04ec 4577 8ffa 9268e60073f5 01)

Chemical structure diagram of glyburide showing its molecular arrangement with atoms and bonds clearly outlined.*

FDA Label Image

Figure A: Single-dose Bioavailability Study (E7421730 04ec 4577 8ffa 9268e60073f5 02)

A line graph titled Figure A showing the concentration (ng/mL) of Glyburide in the blood over time (hours). It compares micronized Glyburide Tablets (3 mg) and nonmicronized Glyburide Tablets (5 mg), illustrating their concentration profiles up to 24 hours.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.